These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18407591)
1. Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats. Wei ZG; Li GX; Huang XC; Zhen L; Yu J; Deng HJ; Qing SH; Zhang C World J Gastroenterol; 2008 Apr; 14(14):2179-86. PubMed ID: 18407591 [TBL] [Abstract][Full Text] [Related]
2. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. Pestieau SR; Schnake KJ; Stuart OA; Sugarbaker PH Cancer Chemother Pharmacol; 2001 Mar; 47(3):269-76. PubMed ID: 11320672 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions. Mohamed F; Stuart OA; Sugarbaker PH J Surg Res; 2003 Jul; 113(1):114-20. PubMed ID: 12943819 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer]. Lin AD; Sun HY; Qu MW; Wang FJ; Wang JY; Li ZJ Ai Zheng; 2002 Apr; 21(4):424-9. PubMed ID: 12452026 [TBL] [Abstract][Full Text] [Related]
6. A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. Mohamed F; Marchettini P; Stuart OA; Yoo D; Sugarbaker PH Eur J Surg Oncol; 2003 Apr; 29(3):261-5. PubMed ID: 12657237 [TBL] [Abstract][Full Text] [Related]
7. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique. Oman M; Tölli J; Naredi P; Hafström LO Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707 [TBL] [Abstract][Full Text] [Related]
8. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Glehen O; Stuart OA; Mohamed F; Sugarbaker PH Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586 [TBL] [Abstract][Full Text] [Related]
9. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Jacquet P; Averbach A; Stephens AD; Stuart OA; Chang D; Sugarbaker PH Oncology; 1998; 55(2):130-8. PubMed ID: 9499187 [TBL] [Abstract][Full Text] [Related]
10. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model. Pestieau SR; Stuart OA; Sugarbaker PH Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617 [TBL] [Abstract][Full Text] [Related]
11. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555 [TBL] [Abstract][Full Text] [Related]
12. [Experimental pharmacokinetic studies of carboplatin intraperitoneal chemotherapy]. Wang J; Chen JQ Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):196-8. PubMed ID: 7956698 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan. Sugarbaker PH; Stuart OA Cancer Chemother Pharmacol; 2007 Feb; 59(2):151-5. PubMed ID: 17091250 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intraperitoneal gemcitabine in a rat model. Pestieau SR; Stuart OA; Chang D; Jacquet P; Sugarbaker PH Tumori; 1998; 84(6):706-11. PubMed ID: 10080682 [TBL] [Abstract][Full Text] [Related]
15. Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients. Moberly JB; Sorkin M; Kucharski A; Ogle K; Mongoven J; Skoufos L; Lin L; Bailey S; Rodela H; Mupas L; Walele A; Ogrinc F; White D; Wolfson M; Martis L; Breborowicz A; Oreopoulos DG Perit Dial Int; 2003; 23(1):63-73. PubMed ID: 12691509 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy. Kuzuya T; Yamauchi M; Ito A; Hasegawa M; Hasegawa T; Nabeshima T J Pharm Pharmacol; 1994 Aug; 46(8):685-9. PubMed ID: 7815285 [TBL] [Abstract][Full Text] [Related]
17. Physiological saline is not a biocompatible peritoneal dialysis solution. Wang T; Heimbürger O; Qureshi AR; Waniewski J; Bergström J; Lindholm B Int J Artif Organs; 1999 Feb; 22(2):88-93. PubMed ID: 10212043 [TBL] [Abstract][Full Text] [Related]
18. Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution. Mehta AM; Huitema AD; Burger JW; Brandt-Kerkhof AR; van den Heuvel SF; Verwaal VJ Ann Surg Oncol; 2017 Apr; 24(4):990-997. PubMed ID: 27896510 [TBL] [Abstract][Full Text] [Related]
19. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites. Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454 [TBL] [Abstract][Full Text] [Related]
20. Peritoneal fluid and solute transport with different polyglucose formulations. Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B Perit Dial Int; 1998; 18(2):193-203. PubMed ID: 9576369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]